Enzymatica Investor Relations Material
Latest events
Study Result
Enzymatica
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Enzymatica
Access all reports
Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases in Sweden and internationally. The company offers ColdZyme, an oral spray for the treatment of common cold; and ear spray for the treatment of otitis media that is primarily intended for infants and small children. Its products are based on its patented enzyme technology, which mimics the body's natural system for managing harmful bacteria. The company markets its products to pharmacies, audiologists, cancer centers, leukemia patients, surgeons, and ENT departments; and online.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
ENZY
Country
🇸🇪 Sweden